← Back to all signals
RESEARCH PAPER ANALYSIS

Ovarian function in adolescents and young adults undergoing cancer treatment: biochemical and ultrasound marker analysis.

AI interpretation is pending for this paper.

Open original publication →
PMID39887687
JournalEndocrine connections
Publication Date2025-02-24
Ingested2026-08-02 12:03 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

OBJECTIVE: Gonadal dysfunction is a major late complication after cancer diagnosis and treatment. We aimed to study the prevalence of premature ovarian insufficiency (POI) and the potential reduction of ovarian reserve in a cohort of adolescent and young adult (AYA) patients undergoing cancer treatments, evaluating ovarian function and reserve markers. We also aimed to analyze how these markers are related to each other and to treatment-related risk factors. METHODS: We performed a retrospective study, including all female AYA patients undergoing cancer treatment during childhood or adolescence, who visited our pediatric gynecology outpatient clinic between January 1, 2018, and August 30, 2023. Serum levels of anti-Mullerian hormone (AMH) and follicle-stimulating hormone (FSH), antral follicle count (AFC) and mean ovarian volume were evaluated. The correlations between these markers and how their alterations are related to treatment-related risk factors were analyzed. RESULTS: The prevalence of POI in 95 patients was 18.9%. A significant positive correlation was observed between AMH levels and both AFC and ovarian volume. AMH was the most reliable serum marker for ovarian function in terms of POI. Independent risk factors for ovarian dysfunction in relation to all the markers analyzed were hematopoietic stem cell transplantation (HSCT) and high doses of alkylating agents (≥6000 mg/m2). CONCLUSION: Gonadal dysfunction and infertility are quite common in AYA patients undergoing cancer treatment. High-dose alkylating agents and HSCT are the independent risk factors. AMH and FSH values, AFC and mean ovarian volume provide different but consistent information for closely monitoring patients after cancer treatment.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 Nuclear export inhibition activates TP53 pathways and is a potent therapeutic strategy in atypical teratoid rhabdoid tumors. Neuro-oncology advances 56.94 2 Delayed Detection of Bilateral High-Frequency Sensorineural Hearing Loss Following Childhood Cisplatin Therapy: A Case Report. The journal of international advanced otology 59.94 3 Conservative Management of a Primary Mandibular Second Molar With Dentoalveolar Abscess in a Four-Year-Old Child With Acute Lymphoblastic Leukemia: A Case Report. Cureus 54.3 4 Machine Learning Comparison and Combined Model Optimization Based on DCE-MRI Radiomics for Preoperative Assessment of Lymphovascular Invasion in Breast Cancer: A Multicenter Study. Cancer reports (Hoboken, N.J.) 65.9 5 Pediatric ALK-Negative Anaplastic Large Cell Lymphoma With Recurrent Cutaneous Relapses: Diagnostic Challenges. Pediatric dermatology 61.62 6 A safety review of jak inhibitors for managing alopecia areata. Expert opinion on drug safety 74.06 7 Support for Disclosure of Hereditary Tumor Risk to Children and Adolescents: A Scoping Review. Japan journal of nursing science : JJNS 78.4 8 Late Ischemic Cholangiopathy After Liver Transplantation From a Deceased Donor With Situs Inversus Totalis: A Case Report. Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 47.5 9 Lived experiences of parenting-related distress in mothers with gynecological cancer: a descriptive phenomenological study. BMC women's health 58.4 10 Vancomycin Taper-and-Pulse Therapy for Recurrent Clostridioides difficile Infection in Pediatric Acute Lymphoblastic Leukemia Patients Treated With Blinatumomab and Chemotherapy: A Report of Three Cases. Cureus 62.34 11 Percutaneous calcium phosphate cement injection for unicameral bone cysts: mid- to long-term clinical and radiographic outcomes. Frontiers in surgery 63.9 12 Radiographic evidence of thymic involution in hepatocellular carcinoma: a propensity score-matched study in viral cirrhosis. Frontiers in immunology 62.5 13 Case Report: Activated phosphoinositide 3-kinase δ syndrome mimicking Hyper-IgM syndrome: early hepatosplenomegaly as a key diagnostic clue. Frontiers in immunology 56.6 14 Herpes zoster frequency and severity in immunocompromised pediatric populations: a structured narrative review. Frontiers in pediatrics 59.0 15 Recognition and management of early complications in CAR-T cell therapy and virus-specific T-lymphocyte therapy: a practical clinical reference. Frontiers in immunology 75.5 16 Gastric dysbiosis and more severe histological gastritis in symptomatic Helicobacter pylori-infected children and adolescents without ulcers: time to rethink early eradication? Frontiers in microbiology 58.4 17 Surgical management and molecular diagnosis of pediatric cystic nephroma: a single-center case series with implications for DICER1 syndrome surveillance. Translational andrology and urology 56.9 18 Infantile Osteopetrosis with a CLCN7 Variant: An Educational Case Highlighting Integrated Diagnosis and Variant Interpretation. EJIFCC 56.0 19 Plexiform neurofibroma of the scrotum in a 16-year-old male: A case report. Urology case reports 45.5 20 Advanced Imaging Techniques for Early in-Vivo Discrimination of Fibrofolliculomas in Birt-Hogg-Dubé Syndrome. Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) 57.5 21 Health Behaviors in Adolescent and Young Adult (AYA) Childhood Cancer Survivors: Prevalence, Determinants, and Comparison With Population Controls. Cancer medicine 66.9 22 Mechanism of Gu-Ben-Hua-Shi (AESS) Formula Regulating Autophagy Through Hippo-YAP Pathway in Restoring the Skin Barrier in Atopic Dermatitis. Journal of cellular and molecular medicine 76.35 23 Mapping Psychosocial Determinants for Cancer Onset: An Umbrella Review. Psycho-oncology 74.9 24 Early-onset colorectal cancer burden attributable to early-life obesity from 2000 to 2020 with projections to 2040. Cancer epidemiology 57.5 25 The effect of unique molecular identifier family size using tumor-informed circulating tumor-DNA analysis in childhood cancers. The Journal of molecular diagnostics : JMD 59.6 26 GATA3-driven CDC20 activation facilitates tumor growth and metastasis through suppressing Bax/Bcl-2 ratio and boosting EMT process in neuroblastoma. The Journal of biological chemistry 60.6 27 [Masked pediatric pathological femoral fracture : Case report of a sarcoma-associated femoral fracture after adequate trauma]. Unfallchirurgie (Heidelberg, Germany) 49.9 28 Antiviral therapies are associated with reduced mortality but under-utilized in patients with viral hepatocellular carcinoma: a multinational REAL-HCC study. Hepatology international 61.1 29 Privacy-Preserving Linkage of Distributed Biological, Clinical, and Imaging Data Supporting Artificial Intelligence in Pediatric Oncology. Methods of information in medicine 71.9 30 Risk and benefit for targeted therapy agents in paediatric phase I trials in oncology: a systematic review and meta-analysis protocol. BMJ open 83.72 31 Testicular Tissue Cryopreservation in Prepubertal Boys: Current Advances, Clinical Feasibility, and Future Directions-A Comprehensive Literature Review. Andrology 63.6 32 Opioid limiting law and opioid prescriptions among Medicaid-enrolled survivors of childhood cancer. Journal of the National Cancer Institute 57.5
PATIENT-FRIENDLY SUMMARY

Ovarian function in adolescents and young adults undergoing cancer treatment: biochemical and ultrasound marker analysis.

For education only—not personal medical advice.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic